High‐flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS‐CoV‐2 pneumonia out of ICU

INTRODUCTION AND OBJECTIVES: High‐flow nasal cannula oxygen therapy (HFNC) has been successfully used for the treatment of acute hypoxaemic respiratory failure (AHRF) secondary to SARS‐CoV‐2 pneumonia and being effective in reducing progression to invasive mechanical ventilation. The objective of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Sonia, Pedrero, Sandra, Ruiz, Luis Alberto, Serrano, Leyre, Zalacain, Rafael, Pérez‐Fernández, Silvia, Iriberri, Milagros, Cabriada, Valentín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500315/
https://www.ncbi.nlm.nih.gov/pubmed/37537998
http://dx.doi.org/10.1111/crj.13679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500315/
https://www.ncbi.nlm.nih.gov/pubmed/37537998
http://dx.doi.org/10.1111/crj.13679

Ejemplares similares